Literature DB >> 24900646

Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins.

Oliver P Horlacher1, Ruben C Hartkoorn2, Stewart T Cole2, Karl-Heinz Altmann1.   

Abstract

Dihydropyridomycins 2 and 3, which lack the characteristic enol ester moiety of the potent antimycobacterial natural product pyridomycin (1), have been prepared from l-Thr, R- and S-hydroxy isovaleric acid, and 3-pyridinecarboxaldehyde. The 2R isomer 2 shows only 4-fold lower anti-Mtb activity than 1, indicating that the enol ester moiety in the natural product is not critical for its biological activity. This finding establishes 2 as a potent and more practical lead for anti-TB drug discovery.

Entities:  

Keywords:  InhA; natural products; pyridomycin; total synthesis; tuberculosis

Year:  2012        PMID: 24900646      PMCID: PMC4027526          DOI: 10.1021/ml300385q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  8 in total

1.  A new antibiotic, pyridomycin.

Authors:  K MAEDA; H KOSAKA; Y OKAMI; H UMEZAWA
Journal:  J Antibiot (Tokyo)       Date:  1953-07       Impact factor: 2.649

Review 2.  Extensively drug-resistant tuberculosis: "there must be some kind of way out of here".

Authors:  J Peter Cegielski
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

3.  The structure of ryridomycin.

Authors:  G Koyama; Y Iitaka; K Maeda; H Umezawa
Journal:  Tetrahedron Lett       Date:  1967-09       Impact factor: 2.415

4.  Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.

Authors:  Catherine Vilchèze; Feng Wang; Masayoshi Arai; Manzour Hernando Hazbón; Roberto Colangeli; Laurent Kremer; Torin R Weisbrod; David Alland; James C Sacchettini; William R Jacobs
Journal:  Nat Med       Date:  2006-08-13       Impact factor: 53.440

Review 5.  Global burden and epidemiology of tuberculosis.

Authors:  Philippe Glaziou; Katherine Floyd; Mario Raviglione
Journal:  Clin Chest Med       Date:  2009-12       Impact factor: 2.878

6.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.

Authors:  A Banerjee; E Dubnau; A Quemard; V Balasubramanian; K S Um; T Wilson; D Collins; G de Lisle; W R Jacobs
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

7.  An antituberculous antibiotic from Streptomyces sp. Studies on the streptomyces antibiotics. XXXII.

Authors:  M KUROYA; B TAKAHASHI; Y HINUMA; T YASHIMA; K WATANABE; S HAMADA
Journal:  J Antibiot (Tokyo)       Date:  1954-03       Impact factor: 2.649

8.  Towards a new tuberculosis drug: pyridomycin - nature's isoniazid.

Authors:  Ruben C Hartkoorn; Claudia Sala; João Neres; Florence Pojer; Sophie Magnet; Raju Mukherjee; Swapna Uplekar; Stefanie Boy-Röttger; Karl-Heinz Altmann; Stewart T Cole
Journal:  EMBO Mol Med       Date:  2012-09-17       Impact factor: 12.137

  8 in total
  6 in total

Review 1.  Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis.

Authors:  Vadim Makarov; Elena Salina; Robert C Reynolds; Phyo Phyo Kyaw Zin; Sean Ekins
Journal:  J Med Chem       Date:  2020-04-20       Impact factor: 7.446

Review 2.  Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

Authors:  Adetomiwa A Adeniji; Kirsten E Knoll; Du Toit Loots
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-05       Impact factor: 4.813

3.  Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA.

Authors:  Ruben C Hartkoorn; Florence Pojer; Jon A Read; Helen Gingell; João Neres; Oliver P Horlacher; Karl-Heinz Altmann; Stewart T Cole
Journal:  Nat Chem Biol       Date:  2013-12-01       Impact factor: 15.040

4.  Characterization of Pyridomycin B Reveals the Formation of Functional Groups in Antimycobacterial Pyridomycin.

Authors:  Tingting Huang; Zihua Zhou; Maolong Wei; Lin Chen; Zhihong Xiao; Zixin Deng; Shuangjun Lin
Journal:  Appl Environ Microbiol       Date:  2022-02-02       Impact factor: 5.005

5.  Synthetic scope and DFT analysis of the chiral binap-gold(I) complex-catalyzed 1,3-dipolar cycloaddition of azlactones with alkenes.

Authors:  María Martín-Rodríguez; Luis M Castelló; Carmen Nájera; José M Sansano; Olatz Larrañaga; Abel de Cózar; Fernando P Cossío
Journal:  Beilstein J Org Chem       Date:  2013-11-11       Impact factor: 2.883

6.  Intragenic Distribution of IS6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance.

Authors:  Rudy Antoine; Cyril Gaudin; Ruben C Hartkoorn
Journal:  Microbiol Spectr       Date:  2021-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.